COLUMBIA, Md., Sept. 6 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK - News) today announced its financial results for the third quarter of fiscal 06 (3rd Qtr 06), which ended July 31, 2006. For the 3rd Qtr 06, revenues of $70.4 million were achieved, compared to $39.5 million for the third quarter of fiscal 05 (3rd Qtr 05). For the 3rd Qtr 06, Martek generated net income of $5.3 million, or $0.16 per diluted share, compared to net loss of $100,000, or $0.00 per diluted share, for the 3rd Qtr 05. For fiscal 2006 year-to-date (06 YTD), revenues of $203.5 million were achieved, a 26% increase over revenues of $161.8 million for fiscal 2005 year-to-date (05 YTD). For 06 YTD, Martek earned net income of $17.2 million, or $0.53 per diluted share, an increase of 65% over net income of $10.4 million or $0.33 per diluted share for 05 YTD.
